Despite the finding that the hemin-controlled translational inhibitor in reticulocyte lysates is a cyclic AMPindependent protein kinase that phosphorylates the small subunit of the initiation factor eIF-2, the mechanism of inhibition of translation remained unexplained. Whereas treatment of hemin-containing lysates with inhibitor in the presence of ATP inhibited translation, the same treatment of highly purified eIF-2 did not affect its ability to form a ternary complex with initiator Met-tRNA and GTP or a 40S initiation complex. We have isolated from ribosomal salt washes a protein (eIF-2 stimulating protein) that enhances the capacity of unphosphorylated eIF-2 to form ternary or 40S initiation complexes but has no effect on the phosphorylated factor. At low concentrations, eIF-2 is virtually inactive without this stimulating protein. Therefore, the translational inhibitor acts by converting eIF-2 to a form that is not stimulated by the stimulating protein.
Despite the finding that the hemin-controlled translational inhibitor in reticulocyte lysates is a cyclic AMPindependent protein kinase that phosphorylates the small subunit of the initiation factor eIF-2, the mechanism of inhibition of translation remained unexplained. Whereas treatment of hemin-containing lysates with inhibitor in the presence of ATP inhibited translation, the same treatment of highly purified eIF-2 did not affect its ability to form a ternary complex with initiator Met-tRNA and GTP or a 40S initiation complex. We have isolated from ribosomal salt washes a protein (eIF-2 stimulating protein) that enhances the capacity of unphosphorylated eIF-2 to form ternary or 40S initiation complexes but has no effect on the phosphorylated factor. At low concentrations, eIF-2 is virtually inactive without this stimulating protein. Therefore, the translational inhibitor acts by converting eIF-2 to a form that is not stimulated by the stimulating protein.
In reticulocytes and other eukaryotic cells the initiator species of eukaryotic Met-tRNA (Met-tRNAj) binding factor eIF-2 is rendered inactive for polypeptide chain initiation by phosphorylation of its small subunit. This reaction is catalyzed (1) (2) (3) (4) , in the presence of ATP, by an adenosine 3',5'-cyclic monophosphate (cAMP)-independent protein kinase (active eIF-2 kinase, inhibitor) and there is evidence (5-7) that the active enzyme arises by phosphorylation of an inactive precursor (inactive eIF-2 kinase, proinhibitor) catalyzed by cAMP-dependent protein kinase. Hemin prevents the proinhibitorinhibitor conversion (8) because it blocks the activation of cAMP-dependent protein kinase by cAMP (6, 7) through binding to the regulatory subunit of the enzyme (unpublished data). eIF-2 forms a ternary complex with Met-tRNAj and GTP which, upon binding to a 40S ribosomal subunit, gives rise to a 40S initiation complex. This sets the stage for elongation of the polypeptide chain.
In the presence of inhibitor and ATP, the rate of protein synthesis in hemin-containing reticulocyte lysates soon shows a sharp decline (9) . Although this effect would appear to be related to the phosphorylation of eIF-2, treatment of purified eIF-2 with inhibitor plus ATP does not interfere with its ability to form ternary or 40S initiation complexes (1, 5, 10) . On the other hand, formation of the complex is impaired when partially purified eIF-2 is used (5, 10) . This suggests that inhibition of translation involves another factor(s) present in lysates and in partially purified eIF-2 preparations. Ribosomal salt washes contain, along with eIF-2, a factor(s) necessary for inhibition of ternary complex formation when purified eIF-2 is treated with inhibitor and ATP. The new factor enhances the ability of unphosphorylated eIF-2 to form ternary or 40S initiation complexes but has no effect on phosphorylated eIF-2; it will be referred to as the eIF-2 stimulating protein (ESP). At the low concentrations present in reticulocyte lysates, eIF-2 is virtually
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with MATERIALS AND METHODS Assays. Ternary complex formation was assayed as described (11) with A. salina [35S]Met-tRNAj (specific radioactivity, 19 ,000-11,000 cpm/pmol), 1.5-3 pmol; GTP, 0.14 mM; and eIF-2 and/or ESP, as specified in the legends. The translational inhibitor, eIF-2 kinase (referred to throughout this paper as the inhibitor) was assayed routinely through its inhibition of ternary complex formation (5) by ESP-containing eIF-2, in the presence of ATP. Fig. I shows the inhibition as a function of either inhibitor or ATP. Note that there was no inhibition in the absence of added ATP and that 0.05-0.1 mM ATP saturated the system (Fig. 1B ). For comparison with other preparations of inhibitor (12) we used the protein synthesis assay (5) . ESP was determined with the ternary complex assay.
We suspected that ribosomal washes contained a factor(s) necessary for inhibition of eIF-2 activity, after incubation with inhibitor and ATP, because such incubation decreased the activity of crude but not of purified preparations of eIF-2 (5, 10). Using the inhibitor assay as a guide, we separated eIF-2 from X, a factor that enhanced the ability of eIF-2 to form a ternary complex. However, X did not enhance eIF-2 activity when inhibitor and ATP were also present. X (ESP) was assayed by measuring ternary complex formation in each of four samples, all containing ESP-free eIF-2 and ATP, with the following reactants: (i) no ESP, no inhibitor; (ii) ESP, no inhibitor; (iii) no ESP, inhibitor; (iv) ESP, inhibitor. In a typical assay the amount of ternary complex formed (pmol/50 Al) was as follows:
(i) 0.38; (ii) 0.78; (iii) 0.37; (iv) 0.39. Thus, ESP doubled the amount of complex formed in the absence of inhibitor (ii -i) and had no effect in the presence of inhibitor (iv -iii). Comparing the data in a different-way, inhibitor depressed complex formation (by 50%) in the presence (ii -iv) but not in the absence (i -iii) of ESP. Therefore, ESP can be assayed in two ways. Assay A: inhibition of ternary complex formation by excess inhibitor plus ATP in samples containing both eIF-2 and ESP (ii -iv). Assay B: enhancement of ternary complex formation by ESP in samples containing eIF-2 but no inhibitor plus ATP (ii-i).
To study the effect of the inhibitor on ternary complex formation after allowing it to act separately, rather than simultaneously, on eIF-2 and ESP (see legend to Fig. 3B ), the ATP was salina embryos (14) . Samples (30 Al) containing N-2-hydroxyethylpiperazine-N'-l-ethanesulfonate (Hepes) buffer, pH 7.6, 40 ,uM; KC1, 100 mM; Mg(OAc)2, 10 mM; diethiothreitol, 4 mM; ATP, 0.67 mM; and inhibitor, eIF-2, and ESP as specified in the legend to Fig. 3C were preincubated for 2 min at 30°. They were then supplemented with GTP, 0.12 mM final concentration; [asS]Met-tRNAi (12, (0) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) 000 cpm/pmol), 8 pmol; and 40S subunit, 1.0 A260 unit, and brought to a final volume of 60 ,1 by addition of enough KCl to make its final concentration 80 mM. After incubation for 20 min at 300 and 5 min at 00, the samples were processed as described (13) . Protein was determined by the method of Lowry et al. (15) with bovine serum albumin as the standard.
Preparations. Partially purified inhibitor (eIF-2 kinase) was prepared from the postribosomal supernatant of commercial (Gibco) rabbit reticulocyte lysate. The procedure involved precipitation with ammonium sulfate, chromatography on DEAE-cellulose [to give a fractiont equivalent to protein kinase DEAE peak III of Traugh and Traut (16), chromatography on phosphocellulose, and filtration on Sephadex G-200. (The details of this procedure will be described elsewhere.) The inhibitor solution (2 mg of protein per ml) was stored in small aliquots in liquid nitrogen. The amount of protein required to decrease protein synthesis in a hemin-containing lysate to the level of inhibition observed in the absence of hemin (taken as 100% inhibition) was assumed to contain 1 unit of inhibitor activity. An amount of inhibitor containing 1.4 Mug of protein caused 100% inhibition in the protein synthesis assay. Its specific activity, 714 units/mg of protein, was similar to that of the step t We are indebted to J. M. Sierra for this material. In a separate experiment, a mixture of muscle aldolase (Ald), ovalbumin (Ova), and ribonuclease A (Rib), molecular weights 152,000, 45,000, and 13,700, respectively, was run on the same column and the fraction numbers corresponding to the elution peaks of the three proteins (0) were plotted against molecular weight (X10-5); 0 corresponds to the ESP activity peak in assay A (see Table 1 ). 4 inhibitor of Ranu and London (12) . The preparation of ESP-free eIF-2 and ESP is described below. Other preparations and materials were as in previous work (5-7). RESULTS Isolation of ESP. ESP and eIF-2 were isolated from the ribosomal salt wash of developing A. salina embryos. Step 1. Ribosomal wash (11) dialyzed overnight against buffer A [20 mM Hepes, pH 7.6/0.1 mM EDTA/1 mM dithiothreitol/5% (vol/vol) glycerol] containing 80 mM KC1.
Step 2. The dialyzed solution (7.5 ml, 21 mg of protein per ml) was applied to a DEAE-cellulose (Whatman DE-52, 1.5 X 8 cm) equilibrated with buffer A containing 80 mM KC1. After the column was washed with the same buffer, eIF-2 and ESP were eluted with buffer A containing 180 mM KC1 (DE-180 fraction).
Step 3. The step 2 fraction was applied to a column (0.6 X 8 cm) of carboxymethyl-Sephadex C-50 (Pharmacia) equilibrated with buffer A containing 180 mM KC1. This separates eIF-2, which is retained by the column, from ESP, which is not retained (ESP CM-180). eIF-2 free from ESP was eluted with buffer A containing 400 mM KC1, yielding 2 ml of solution containing 3 mg of protein (eIF-2 CM-400). It was stored in small aliquots in liquid nitrogen. The specific activity of this preparation (ternary complex assay with excess ESP) was 125 pmol/mg of protein.
Step 4. The protein in the CM-180 effluent fraction was concentrated by precipitation with ammonium sulfate between 25 and 80% saturation. The precipitate was dissolved in 2.5 ml of buffer A, and the solution was dialyzed overnight against the same buffer. The dialyzed solution was passed through a column of carboxymethyl-Sephadex C-50 as above, previously equilibrated with buffer A. ESP (CM-0) is not retained.
Step 5. The ESP fraction CM-0 was chromatographed on Sephadex G-200 (0.9 X 57 cm column) with buffer A as eluent; 0.5-ml fractions were collected. The bulk of the ESP activity was eluted in fractions [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] (Fig. 2) . Fractions 32-41 were pooled to give a solution containing 1.6 mg of protein per ml (ESP SE-200) and stored in small aliquots in liquid nitrogen.
A summary of the preparation of ESP is given in Table 1 . The molecular weight of ESP (see Fig. 2 ) is approximately 180,000. eIF-2 CM-400 and ESP SE-200 were used throughout the following studies unless otherwise specified. Assay at steps 1 and 2, prior to separation of ESP from eIF-2, was only qualitative. eIF-2 CM-400 (see text), 6 Ag per sample, was added for assay at steps 3-5. Assay A (see Materials and Methods) was used. * One unit is the amount of protein required to obtain 50% inhibition of ternary complex formation with purified eIF-2 in the presence of excess inhibitor and ATP. t Units/mg of protein.
Effect of ESP and Inhibitor on Initiation Complex Formation. Because ESP was isolated as a factor required for inhibition of ternary complex formation with purified eIF-2 upon incubation with inhibitor and ATP, we were surprised to find (Fig. 3A) that, in the absence of inhibitor, ESP actually stimulated complex formation (bars 1 and 2). In the presence of inhibitor and ATP (bars 3 and 4), ESP was without effect. Enhancement of the activity of eIF-2 by ESP probably involves interaction of the two factors. Hence, blocking of this interaction could be caused by (i) phosphorylation of the 38,000-dalton subunit of eIF-2 alone, (ii) phosphorylation of ESP alone, or (i ) phosphorylation of both eIF-2 and ESP. Fig. 3B (Fig. 3B , bars A and B) but the same treatment of ESP alone did not affect its interaction with eIF-2 (Fig. 3B, bars C and D) . Comparison of black bars in A and B and the corresponding ones in C and D show that ATP was effectively removed by the charcoal treatment, because inhibitor was without effect unless ATP was added again. Fig. 3C and D show that what is true of ternary complex is also true of 40S initiation complex formation. Thus, with ESP-containing eIF-2, formation of 40S complex was decreased when the samples contained inhibitor and ATP (Fig.  SC, bars 1 and 2) . With ESP-free eIF-2, ESP stimulated 40S complex formation in the absence (Fig. 3C and D, bars and samples 3 and 4) but not in the presence (bars and samples 5 and 6) of inhibitor and ATP.
The enhancement of ternary complex formation by eIF-2 in the presence of increasing concentrations of ESP is shown in Fig. 4A . Note that no complex was formed when ESP was present without either GTP or eIF-2. The kinetics of ternary complex formation with and without ESP and/or inhibitor plus ATP are shown in Fig. 4B . Maximal complex formation required 5-7 min. ESP increased not only the extent but also the rate of complex formation. Again, inhibitor plus ATP had no effect in the absence of ESP but virtually abolished the ability of the latter to enhance complex formation. ESP ternary complex formation as much as 20-fold at low eIF-2 concentrations but was virtually without effect at high concentrations ( (11, 17, 18) to SH-binding reagents (Table 3) . N-Ethlymaleimide at 20 mM or p-chloro-mercuribenzenesulfonic acid at 1.0 mM inhibited ESP stimulation of ternary complex formation by more than 80%; 2.0 mM p-chloromercuribenzenesulfonic acid inhibited ESP and eIF-2 activity to the same extent, 95%.
DISCUSSION
The activity of a ribosomal wash factor that enhances the ability of eIF-2 to form ternary or 40S initiation complexes is abolished by incubation of eIF-2 with inhibitor and ATP. We call the new factor "ESP" for "eIF-2 stimulating protein." Its molecular weight is approximately 180,000 and, like eIF-2, it has SH groups that are essential for activity. The effect of ESP on ternary complex formation is similar to that of a factor described by Dasgupta et al. (19) . Incubation of eIF-2 with eIF-2 kinase and ATP is without effect on complex formation (whether ternary or 40S) unless ESP is present. A report that phosphorylation of eIF-2 inhibited 40S but not ternary complex formation (20) can be explained by the fact that ternary complex Table 2 ), the ability of eIF-2 to form a ternary complex is almost negligible in the absence of ESP. Because the effect of ESP is prevented by incubation of eIF-2 with inhibitor and ATP, the observations reported in this paper fully elucidate the mechanism by which phosphorylation of the eIF-2 present in reticulocyte lysates inhibits chain initiation. They also explain why addition of large amounts of eIF-2 relieves this inhibition (9 
